These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6787171

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Subacute L-DOPA in mice: biochemical and behavioural effects.
    Jenkins O, Bailey R, Crisp E, Jackson DM.
    Psychopharmacology (Berl); 1980; 68(1):77-83. PubMed ID: 6771801
    [Abstract] [Full Text] [Related]

  • 3. Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.
    Jackson DM, Jenkins OF, Malor R, Christie MJ, Gregory P.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):271-4. PubMed ID: 6686648
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
    Tabar J, Hashizume M, Cook CJ, Beart PM, Jackson DM.
    Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
    Fayle P, Jackson DM, Jenkins OF, Lafferty PA.
    Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
    [Abstract] [Full Text] [Related]

  • 9. Behavioural and biochemical effects of subchronic treatment with raclopride in the rat: tolerance and brain monoamine receptor sensitivity.
    Ahlenius S, Ericson EL, Högberg K, Wijkström A.
    Pharmacol Toxicol; 1991 Apr; 68(4):302-9. PubMed ID: 1907738
    [Abstract] [Full Text] [Related]

  • 10. [Central action of beta-phenylethylamine derivatives (10). Effect of L-Dopa on metaraminol induced motor activity (author's transl)].
    Shoji T, Tadano T, Kisara K.
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):371-8. PubMed ID: 908541
    [Abstract] [Full Text] [Related]

  • 11. An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice.
    Archer T, Fredriksson A.
    J Neural Transm (Vienna); 2003 Feb; 110(2):183-200. PubMed ID: 12589577
    [Abstract] [Full Text] [Related]

  • 12. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD, Cooper DR, Fleminger S, Rupniak NM, Jenner P, Marsden CD.
    Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
    [Abstract] [Full Text] [Related]

  • 13. Antagonism of ethanol's central stimulation in mice by small doses of catecholamine-receptor agonists.
    Strömbom U, Svensson TH, Carlsson A.
    Psychopharmacology (Berl); 1977 Mar 16; 51(3):293-9. PubMed ID: 403547
    [Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA.
    Ponzio F, Cimino M, Achilli G, Lipartiti M, Perego C, Vantini G, Algeri S.
    Life Sci; 1984 May 28; 34(22):2107-16. PubMed ID: 6145075
    [Abstract] [Full Text] [Related]

  • 15. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G, Ross SB, Kelder D, Edis LE, Jackson DM.
    Pharmacol Toxicol; 1990 Aug 28; 67(2):123-31. PubMed ID: 1979437
    [Abstract] [Full Text] [Related]

  • 16. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.
    Dunstan R, Jackson DM.
    Clin Exp Pharmacol Physiol; 1977 Aug 28; 4(2):131-41. PubMed ID: 195762
    [Abstract] [Full Text] [Related]

  • 17. Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
    Kuschinsky K.
    Psychopharmacologia; 1975 Jun 19; 42(3):225-9. PubMed ID: 1172252
    [Abstract] [Full Text] [Related]

  • 18. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine).
    Jackson D, Carlsson A, Hjorth S, Lindberg P.
    J Neural Transm; 1982 Jun 19; 53(4):233-45. PubMed ID: 6286867
    [Abstract] [Full Text] [Related]

  • 19. Locomotor activity and dopamine synthesis following 1 and 15 days of withdrawal from repeated apomorphine treatments.
    Rowlett JK, Mattingly BA, Bardo MT.
    Pharmacol Biochem Behav; 1997 Jun 19; 57(1-2):13-8. PubMed ID: 9164548
    [Abstract] [Full Text] [Related]

  • 20. The role of dopamine in the expression of morphine withdrawal.
    el-Kadi AO, Sharif SI.
    Gen Pharmacol; 1998 Apr 19; 30(4):499-505. PubMed ID: 9522166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.